Participants 74 142 6
allergic rhinitis: study protocol for a randomized controlled trial.
Participants 208 243 3
persistent allergic rhinitis (PER),
Participants 415 522 7
multicenter, randomized, controlled clinical trial on PER will be conducted at three institutions in China.
Participants 608 661 8
240 eligible participants with PER will be randomized
